Chiodo F - Search Results

1

Paradoxical immune reconstitution inflammatory syndrome associated with previous Cryptococcus neoformans infection in an HIV-positive patient requiring neurosurgical intervention.

Biagetti C, Nicola M, Borderi M, Pavoni M, Tampellini L, Verucchi G, Chiodo F. Biagetti C, et al. Among authors: chiodo f. New Microbiol. 2009 Apr;32(2):209-12. New Microbiol. 2009. PMID: 19579702 Free article.

2

Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infection.

Biagetti C, Bon I, Vitone F, Schiavone P, Borderi M, Pavoni M, Verucchi G, Re MC, Chiodo F. Biagetti C, et al. Among authors: chiodo f. New Microbiol. 2009 Apr;32(2):129-34. New Microbiol. 2009. PMID: 19579688 Free article.

3

Metabolic complications of HIV-1 antiretroviral therapy: the lipodystrophy syndrome.

Borderi M, Verucchi G, Tadolini M, Spinosa S, Fortunato L, Talò S, Chiodo F. Borderi M, et al. Among authors: chiodo f. New Microbiol. 2001 Jul;24(3):303-15. New Microbiol. 2001. PMID: 11497090 Review.

4

HIV-1, HAART and bone metabolism.

Borderi M, Farneti B, Tampellini L, Giuliani R, Verucchi G, Vescini F, Caudarella R, Chiodo F. Borderi M, et al. Among authors: chiodo f. New Microbiol. 2002 Jul;25(3):375-84. New Microbiol. 2002. PMID: 12173783 Review.

5

Prevalence and virologic consequences of HIV-1 genotype mutations detected in a cohort of 161 Italian patients receiving a nelfinavir-based highly active antiretroviral therapy.

Calza L, Borderi M, Farneti B, Tampellini L, Re MC, Monari P, Bon I, Chiodo F. Calza L, et al. Among authors: chiodo f. J Chemother. 2003 Apr;15(2):165-72. doi: 10.1179/joc.2003.15.2.165. J Chemother. 2003. PMID: 12797395

6

Cardiovascular risk factors and ultrasound evaluation of carotid atherosclerosis in patients with HIV-1 infection.

Calza L, Verucchi G, Pocaterra D, Pavoni M, Alfieri A, Cicognani A, Manfredi R, Serra C, Chiodo F. Calza L, et al. Among authors: chiodo f. Int J STD AIDS. 2009 Oct;20(10):683-9. doi: 10.1258/ijsa.2009.008504. Int J STD AIDS. 2009. PMID: 19815912

7

Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia.

Calza L, Manfredi R, Colangeli V, Tampellini L, Sebastiani T, Pocaterra D, Chiodo F. Calza L, et al. Among authors: chiodo f. AIDS. 2005 Jul 1;19(10):1051-8. doi: 10.1097/01.aids.0000174451.78497.8f. AIDS. 2005. PMID: 15958836 Clinical Trial.

8

Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study.

Calza L, Colangeli V, Manfredi R, Legnani G, Tampellini L, Pocaterra D, Chiodo F. Calza L, et al. Among authors: chiodo f. AIDS. 2005 Jul 1;19(10):1103-5. doi: 10.1097/01.aids.0000174458.86121.43. AIDS. 2005. PMID: 15958843

9

Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitors.

Calza L, Manfredi R, Colangeli V, Pocaterra D, Pavoni M, Chiodo F. Calza L, et al. Among authors: chiodo f. Curr HIV Res. 2008 Nov;6(6):572-8. doi: 10.2174/157016208786501481. Curr HIV Res. 2008. PMID: 18991624 Clinical Trial.

10

Efficacy and safety of atazanavir-ritonavir plus abacavir-lamivudine or tenofovir-emtricitabine in patients with hyperlipidaemia switched from a stable protease inhibitor-based regimen including one thymidine analogue.

Calza L, Manfredi R, Colangeli V, Pocaterra D, Rosseti N, Pavoni M, Chiodo F. Calza L, et al. Among authors: chiodo f. AIDS Patient Care STDS. 2009 Sep;23(9):691-7. doi: 10.1089/apc.2009.0039. AIDS Patient Care STDS. 2009. PMID: 19739937 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

434 results

Search Page